The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health

The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have emerged as a promising therapeutic option beyond their established role in managing type 2 diabetes mellitus (T2DM) and obesity. Recent research has highlighted their beneficial effects on liver, kidney, and cardiovascular health, mediated b...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamad Al Qassab, Mohammad Mneimneh, Ahmad Jradi, Bassem Derbas, Dana Dabboussi, Justine Khoury Baini, Nadia Katrib, Nadim Chaarani, Philippe Attieh, Amjad Kanaan, Frederic Harb, Sami Azar, Hilda E. Ghadieh
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Current Issues in Molecular Biology
Subjects:
Glucagon-like peptide 1 receptor agonists
metabolic health
type 2 diabetes mellitus
diabetic nephropathy
fatty liver disease
cardiovascular diseases
Online Access:https://www.mdpi.com/1467-3045/47/4/285
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1467-3045/47/4/285

Similar Items